期刊文献+

中医治疗肿瘤评价方法现状与体会 被引量:5

On the Tumor Therapeutic Effect Assessment in Traditional Chinese Medicine
下载PDF
导出
摘要 要在更大范围内推广应用中医药治疗肿瘤的有效方法,就需要对其临床疗效进行科学、客观的研究和评价。从中医治疗肿瘤的特色出发,在对常规的疗效评定标准进行系统评价的基础上,建立起包括现代医学疾病疗效评价、中医证候疗效评价、生存质量评价等在内的中医肿瘤疗效综合评价指标体系,使其能更科学、更准确地反映中医药防治疾病所具有的真正效能,并有利于中医药防治肿瘤的效果为国际医学界所接受。 To widely apply the effective treatment of traditional Chinese medicine (TCM) in cancer therapy, objective and scientific research methods will be needed to assess the therapeutic effect of TCM. Based on the systematic evaluation of the routine standards of therapeutic effect assessment, and following the characteristic of clinical practice of TCM, an integrated indexing system was established in this study for the assessment of tumor TCM treatment, includ- ing the therapeutic effect assessment in modern medicine, syndrome therapeutic effect assessment in TCM, life quality evaluation. This assessment system will not only reflect the genuine efficacy of the preventive and therapeutic effect of TCM, but also help to introduce the TCM efficacy of tumor treatment to the outside world.
作者 林洪生 张英
出处 《世界科学技术-中医药现代化》 2009年第5期739-741,共3页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金 国家科学技术部"十一五"国家科技支撑计划(2006BAI04A05):非小细胞肺癌中医综合治疗方案的研究 负责人:林洪生
关键词 肿瘤 中医药疗法 疗效评价 Tumor Traditional Chinese Medicine (TCM) Therapeutic Effect Assessment
  • 相关文献

参考文献7

二级参考文献34

  • 1周岱翰,林丽珠.金水宝胶囊对36例晚期癌症患者免疫功能的影响[J].中国中西医结合杂志,1995,15(8):476-478. 被引量:18
  • 2罗健,孙燕.癌症患者的生活质量研究(一)[J].中国肿瘤,1995,4(10):15-19. 被引量:34
  • 3罗健,孙燕.癌症患者的生活质量研究[J].国外医学(肿瘤学分册),1995,22(2):109-112. 被引量:46
  • 4Beitz J,Gnecco C,Justice R.Quality of life end points incancer clinical trials:the US Food and Drug Administration perspective.J Natl Cancer Inst Monogr 1996 ;20:7-9.
  • 5中国抗癌协会编.新编常见恶性肿瘤诊治规范(第九分册)[M].北京:中国协和医科大学出版社,1997.737-781.
  • 6.国际抗癌联盟AJCC/UICC肺癌分期(97国际肺癌分期)标准[A].见:周际昌主编.实用肿瘤内科学[C].北京:人民卫生出版社,1999.23.
  • 7汤钊猷.现代肿瘤学(第2版)[M].上海:上海医科大学出版社,1999.22.
  • 8Frost MH,Bonomi AE,Ferrans CE,et al.Patient,clinician,and population perspectives on determination of the clinical significance of quality-of-life scores.Mayo Clin Proc 2002;77(5):488-494.
  • 9Breathnach OS,Freidlin B,Conley B,et al.Twenty-two years of phase Ⅲ trials for patients with advanced non-small cell lung cancer:sobering results.J Clin Oncol 2001 ;19(6):1734-1742.
  • 10Cella D.Impact of ZD1839 on non small-cell lung cancer-related symptoms as measured by the functional assessment of cancer therapy-lung scale.Semin Oncol 2003; 30 (Suppl 1):39-48.

共引文献216

同被引文献52

引证文献5

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部